You have to be signed in to use this resource.
“Signatures of Mutational Processes in Human Cancer”
Prof Mike Stratton is the Director of the Wellcome Sanger Institute and Chief Executive Officer of the Wellcome Genome Campus. His primary research interests have been in the genetics of cancer. Mike mapped and identified the major high-risk breast cancer susceptibility gene BRCA2 and subsequently a series of moderate-risk breast cancer and other cancer susceptibility genes. Prof Mike Stratton initiated the Cancer Genome Project at the Wellcome Sanger Institute which conducts systematic genome-wide searches for somatic mutations in human cancer. Through these studies he discovered somatic mutations of the BRAF gene in malignant melanoma and several other mutated cancer genes in lung, renal, breast and other cancers. He has described the basic patterns of somatic mutation in cancer genomes revealing underlying DNA mutational and repair processes.
Resource details
Contributed by: | Pathology Portal |
Authored by: |
|
Licence: | More information on licences |
Last updated: | 20 October 2022 |
First contributed: | 20 October 2022 |
Audience access level: | Full user |
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.